Interested in finding more jobs in Glendale, CA? Click Here to create a Climber profile today!



Ista Pharmaceuticals Work Values

Interested in finding out if you are the type of person this company is looking for? Create an account and take our patented DNA assessment now to see how you compare.


Daily Duties at Ista Pharmaceuticals:

Sold BROMDAY once daily ophthalmic NSAID for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery. Sold BEPREVE a histamine H1 receptor antagonist indicated for the treatment of itching signs and symptoms of allergic conjunctivitis. Main Clients - Ophthalmologists, Optometrist, and Allergists


What they like about Ista Pharmaceuticals:

The social vibrance of a hiring firm is very important to you. Your ability to make and maintain friendships there is a critical part of your decision. You would likely be dissatisfied with a workplace that is quiet, cold, or otherwise not particularly social. When you investigate a new hiring company, ask recruiters, managers, and potential co-workers about the social life and opportunities there. This is especially important when you are relocating; moving dramatically alters your social sphere both inside and outside the workplace.



Information about Ista Pharmaceuticals


Company Rank: Not Available

Average length of employment : 1 year

Average salary of employees: $81,000

These are some of the questions we asked our climbers about their experiences with Ista Pharmaceuticals:

05|
Were your performance expectations clearly communicated?

0.0

Were you recognized for meeting or exceeding expectations?

0.0

Did you feel like your personal contribution was important?

0.0

Was your career path clearly outlined and discussed?

0.0


03|
I would recommend this as a place of employment.
0.0
I believe in the purpose of this organization.
0.0
I would work for this organization again.
0.0
I feel employees are fairly compensated.
0.0


Climbers who worked at Ista Pharmaceuticals had these interests:

Magazines
Popular Science The latest developments in all tech


Back